Editorial: methotrexate vs azathioprine—do differential rates of discontinuation settle the debate? Authors’ reply

Abhinav Vasudevan; Danny Con; Steven Nicolaides; Daniel R. van Langenberg

doi:10.1111/apt.16095

Editorial: methotrexate vs azathioprine—do differential rates of discontinuation settle the debate? Authors’ reply

Abhinav Vasudevan, Danny Con, Steven Nicolaides, Daniel R. van Langenberg

Research output: Contribution to journal › Editorial › Other › peer-review

Original language	English
Pages (from-to)	1529-1530
Number of pages	2
Journal	Alimentary Pharmacology & Therapeutics
Volume	52
Issue number	9
DOIs	https://doi.org/10.1111/apt.16095
Publication status	Published - 1 Nov 2020

Access to Document

10.1111/apt.16095

Cite this

@article{a111cb9f6693427ea1145d8b3dca011c,

title = "Editorial: methotrexate vs azathioprine—do differential rates of discontinuation settle the debate? Authors{\textquoteright} reply",

author = "Abhinav Vasudevan and Danny Con and Steven Nicolaides and {van Langenberg}, {Daniel R.}",

year = "2020",

month = nov,

day = "1",

doi = "10.1111/apt.16095",

language = "English",

volume = "52",

pages = "1529--1530",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Editorial

T2 - methotrexate vs azathioprine—do differential rates of discontinuation settle the debate? Authors’ reply

AU - Vasudevan, Abhinav

AU - Con, Danny

AU - Nicolaides, Steven

AU - van Langenberg, Daniel R.

PY - 2020/11/1

Y1 - 2020/11/1

UR - http://www.scopus.com/inward/record.url?scp=85092163355&partnerID=8YFLogxK

U2 - 10.1111/apt.16095

DO - 10.1111/apt.16095

M3 - Editorial

C2 - 33263380

AN - SCOPUS:85092163355

SN - 0269-2813

VL - 52

SP - 1529

EP - 1530

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 9

ER -

Editorial: methotrexate vs azathioprine—do differential rates of discontinuation settle the debate? Authors’ reply

Access to Document

Other files and links

Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease

Cite this